DailyWealth Investment Newsletter  

About DailyWealth Premium Content DailyWealth Archive
DailyWealth Investment Newsletter DailyWealth Contributors DailyWealth Resources DailyWealth Market Window
 
DailyWealth Print Edition Print Edition | Sponsored Link:
True Wealth Login

Touring One of the Richest Regions in the World... the Hard Way
by Tom Dyson
July 28, 2006

When a friend from work invited me on a short bike tour the other day, it sounded like a good idea…

The plan was to attend an investment conference in Vancouver. But instead of flying direct to Vancouver, we’d fly to Seattle and bike the rest of the way. “It’s about 200 miles and takes four days,” he told me.

I love the Pacific Northwest. It’s a corner of the world I expect will prosper for many years to come. So I accepted the invitation and met Mike at the Seattle airport last week. We purchased cheap road bikes from Wal-Mart and started peddling north.

There are two bike routes from Seattle to Vancouver. One is flat and direct. The other is longer and hillier. We wanted more scenery and less traffic, so we chose the up-and-down route. Besides, I thought I’d see more of the landscape this way.
Advertisement

Last year, I concluded that Asian growth is propelling a boom in the Pacific Northwest. I found more evidence on my bicycle...

We were changing a flat tire in front of a luxury car dealership in the outskirts of Vancouver when the owner came by. His glassed were encrusted with rhinestones and he wore a large diamond ring on his left hand. I asked him if business was good. “Oh, we do very well,” he told me.

We were surrounded by dozens of sleek-looking Porches, BMWs and Range Rovers. “You’d be amazed. I’ll sell most of these to exchange students from Asia. Their daddies send them here to study. They want expensive cars to drive to class in…”

The richest people in Vancouver, he said, are the definitely the Asians.

Immense natural wealth is another reason to like this region. We ogled forests that stretched into the distance for thousands of square kilometers. We peddled by mines and quarries. Huge trucks carrying lumber and mulch roared past on the highways. We even passed the fields that supply much of the world’s daily grain requirements.

Transport infrastructure is something I always watch when I travel. Natural resources are worthless if you can’t bring them to market. We watched huge container ships sail down the Strait of Juan De Fuca and into the ocean. We saw them loading a huge ship with coal in Vancouver’s high-tech Deltaport. And occasionally, we’d hear the call of a freight train snaking through the valleys at night.

All considered, I’d say the freight transport network in the Pacific Northwest may be the best in the world.

Add it all together – Asian growth, vast supplies of natural resources and the means to shift them across the Pacific, and I see the makings of a long-term boom in the Pacific Northwest. My favorite plays are still the large railroads in the region – Canadian National, BNSF and Canadian Pacific. I see decades of great business conditions for these companies ahead.

I learned something else too. Riding a bike for eight hours, day after day, hill after hill, is no sunset cruise along the boardwalk. I felt pain everywhere.

I had cramps in my legs and blisters on my feet. The sun burned my face and arms and the sweat stung my eyes. My lower back ached. I felt mental anguish too. But the worst pain...

I felt the worst pain between my legs where my skin rubbed against the saddle. I’ll save you the details. Let’s just say I couldn’t sit down for a few days after the trip...

Good investing,

Tom

Email a Friend

Delicious
Reddit

Digg

RSS

A GIANT TREND IS GETTING UNDERWAY… ARE YOU IN?

The giant stocks of the drug sector are marching higher… and DailyWealth isn’t surprised.

Our colleague Jeff Clark has been predicting an uptrend in Big Pharma all year. As Jeff points out, industry leaders like Pfizer, Merck, and Johnson & Johnson are rock-solid businesses offering high dividends and bargain P/E ratios.

These stocks have plenty of negative sentiment also. Investors have lost money here for seven long years. But as our chart today shows, the big boys of pharmaceuticals are finally moving higher and rewarding shareholders.

For the full story – and Jeff’s latest comments on this trend - we encourage you to read today’s issue of the Growth Stock Wire. It’s Jeff’s latest project… a great stock market guide… and our favorite new FREE e-letter.

Big Pharma rises… the past 2 years in the Pharmaceutical ETF:

pharma stock etf chart

-Brian Hunt


“In a signal embarrassment for the U.S. Supreme Court, the Ohio Supreme Court ruled unanimously Wednesday that a Cincinnati suburb can’t use eminent domain to take private property for a $125 million multiuse redevelopment.

It was the first challenge of a city’s right of eminent domain to be decided by a state high court since the U.S. Supreme court ruled last summer that economic benefit constitutes ‘public use’ under the Constitution.”

-Investor’s Business Daily

“We're still on the road to World War III. Things were looking a little grim last week - all those countries pressuring us to call for an immediate cease-fire, but we stayed strong.

Sure, we sent over Condi Rice to negotiate, but she's not there for cease-fire. No, she's there for 'sustainable cease-fire,’ which considering the Middle East, is like sending her to bring back Jimmy Hoffa on a unicorn.”

-Stephen Colbert

“It is apparent, in light of the rebirth of the State of Israel, that the present day events in the Holy Land may very well serve as a prelude or forerunner to the future Battle of Armageddon and the glorious return of Jesus Christ.”

- Jerry Falwell

Advertisement

Home | About DailyWealth | Premium Content | DailyWealth Archive | Contributors
DailyWealth Resources | Research Reports | Privacy Policy

Customer Service: 1-888-261-2693 – Copyright 2008 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202